New drug tested to stop strokes after brain bleeds
NCT ID NCT06863480
Summary
This early-stage study is testing a drug called tocilizumab-aazg (TYENNE) in patients who have recently had a brain aneurysm bleed. The main goal is to see if the drug is safe for these patients and to get an early signal on whether it might help prevent delayed strokes, a common and serious complication. About 30 adult patients will receive a single dose of the drug to monitor for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANEURYSMAL SUBARACHNOID HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Florida Health (UF Health)
RECRUITINGGainesville, Florida, 32608, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.